Pricing Log in Create free account

Johnson & Johnson (JNJ) vs Novartis AG (NVS)

Johnson & Johnson and Novartis AG are both Drug Manufacturers General companies. Johnson & Johnson is the larger, with a market value of $610.4B against $275.3B — 2.2× the size. Novartis AG trades at the lower P/E: 22.6× against 29.6×. Johnson & Johnson grew revenue faster over the last twelve months: 7.80% against 2.73%. Novartis AG has the higher net margin (22.5% vs 16.2%) and the higher return on invested capital (13.1% vs 0.00%). Both pay a dividend; Novartis AG yields more (3.15% vs 2.07%). Across the 23 metrics below, Novartis AG leads on 16 and Johnson & Johnson on 7.

Valuation

Metric JNJ NVS Drug Manufacturers General median
P/E 29.61 22.62 24.54
P/S 6.19 5.06 3.39
P/B 7.24 6.84 5.00
Price to free cash flow 27.07 18.91 16.55
EV/EBITDA 18.12 14.47 13.82
EV/Sales 6.36 5.76 4.03
Earnings yield 3.38% 4.42% 2.98%
Free cash flow yield 3.69% 5.29% 4.46%

Profitability

Metric JNJ NVS Drug Manufacturers General median
Gross margin 67.56% 74.74% 72.77%
Operating margin 19.29% 30.17% 18.77%
Net margin 16.20% 22.50% 8.27%
Free cash flow margin 0.00% 26.77% 17.18%
Return on equity 0.00% 30.37% 5.87%
Return on assets 0.00% 11.27% 2.57%
Return on invested capital 0.00% 13.14% 6.11%

Growth

Metric JNJ NVS Drug Manufacturers General median
Revenue growth (TTM) 7.80% 2.73% 6.66%
EPS growth (last fiscal year) 90.50% 21.81% 21.81%
Revenue growth, 5-year CAGR 2.67% 2.58% 4.75%
Net income growth, 5-year CAGR 12.74% 11.62% 0.00%

Health

Metric JNJ NVS Drug Manufacturers General median
Debt to equity 0.44 1.12 0.63
Current ratio 1.09 0.86 1.32
Net debt to EBITDA 0.46 0.96 1.15

Dividend

Metric JNJ NVS Drug Manufacturers General median
Dividend yield 2.07% 3.15% 2.33%
Payout ratio 0.80 0.72 0.59

Size

Metric JNJ NVS Drug Manufacturers General median
Market cap 610.38b 275.28b 123.73b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack